Literature DB >> 30715940

Excess Cardiovascular Risk in Type 1 Diabetes Mellitus.

John R Petrie1, Naveed Sattar1.   

Abstract

Entities:  

Keywords:  Editorials; autoimmunity; cardiovascular diseases; coronary disease; diabetes mellitus, type 1; myosins; vascular calcification

Mesh：

Year:  2019        PMID： 30715940     DOI： 10.1161/CIRCULATIONAHA.118.038137

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  7 in total

1.  Fibronectin-Integrin α5 Signaling in Vascular Complications of Type 1 Diabetes.

Authors:  Minghao Chen; Rui Hu; Cristina Cavinato; Zhenwu W Zhuang; Jiasheng Zhang; Sanguk Yun; Pablo Fernandez Tussy; Abhishek Singh; Sae-Il Murtada; Keiichiro Tanaka; Min Liu; Carlos Fernández-Hernando; Jay D Humphrey; Martin A Schwartz
Journal:  Diabetes       Date:  2022-09-01       Impact factor: 9.337

2.  Efficacy and safety of liraglutide in type 1 diabetes by baseline characteristics in the ADJUNCT ONE and ADJUNCT TWO randomized controlled trials.

Authors:  Thomas F Dejgaard; Bernt J von Scholten; Erik Christiansen; Frederik F Kreiner; Lars Bardtrum; Matthias von Herrath; Chantal Mathieu; Sten Madsbad
Journal:  Diabetes Obes Metab       Date:  2021-09-28       Impact factor: 6.408

Review 3.  Diabetes type 1: Can it be treated as an autoimmune disorder?

Authors:  Natalia G Vallianou; Theodora Stratigou; Eleni Geladari; Christopher M Tessier; Christos S Mantzoros; Maria Dalamaga
Journal:  Rev Endocr Metab Disord       Date:  2021-03-17       Impact factor: 6.514

Review 4.  Metformin and cardiorenal outcomes in diabetes: A reappraisal.

Authors:  John R Petrie; Peter R Rossing; Ian W Campbell
Journal:  Diabetes Obes Metab       Date:  2020-02-18       Impact factor: 6.577

Review 5.  Current and future therapies for type 1 diabetes.

Authors:  Bernt Johan von Scholten; Frederik F Kreiner; Stephen C L Gough; Matthias von Herrath
Journal:  Diabetologia       Date:  2021-02-17       Impact factor: 10.122

6.  The MEK inhibitor U0126 ameliorates diabetic cardiomyopathy by restricting XBP1's phosphorylation dependent SUMOylation.

Authors:  Tao Wang; Jinhua Wu; Wei Dong; Mengwen Wang; Xiaodan Zhong; Wenjun Zhang; Lei Dai; Yang Xie; Yujian Liu; Xingwei He; Wanjun Liu; Thati Madhusudhan; Hesong Zeng; Hongjie Wang
Journal:  Int J Biol Sci       Date:  2021-07-13       Impact factor: 6.580

7.  Type 1 Diabetes Impairs Cardiomyocyte Contractility in the Left and Right Ventricular Free Walls but Preserves It in the Interventricular Septum.

Authors:  Anastasia Khokhlova; Tatiana Myachina; Denis Volzhaninov; Xenia Butova; Anastasia Kochurova; Valentina Berg; Irina Gette; Gleb Moroz; Svetlana Klinova; Ilzira Minigalieva; Olga Solovyova; Irina Danilova; Ksenia Sokolova; Galina Kopylova; Daniil Shchepkin
Journal:  Int J Mol Sci       Date:  2022-02-02       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.